Who owns BeOne Medicines (ONC)? Superinvestor holders

6 superinvestors of the 157 tracked here hold BeOne Medicines (ONC) in their latest 13F filing, with $5B between them. Julian and Felix Baker gives it the most weight: 12.6% of the reported portfolio.

Zhang Lei sold out of it in their latest quarter.

Hold it now
6
of 157 tracked
Combined value
$5B
Bought / sold
4 / 3
last quarter

Key facts

Superinvestors holding it
6 of 157
Biggest holder
Julian and Felix Baker, $2.5B
Largest weight
Julian and Felix Baker, 12.6%of their portfolio
Combined value
$5B
Bought last quarter
4
Sold last quarter
3

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding ONC, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Julian and Felix BakerBaker Bros. Advisors12.6%$2.5B8.8M▲ Added 0.03%+2.64KQ2 2026
2Primecap teamPrimecap Management1.11%$1.8B4.91M▼ Reduced 2.0%−101.16KQ3 2026
3Ken GriffinCitadel Advisors0.23%$406.2M1.43M▲ Added 38%+393.21KQ2 2026
4Sarah KettererCauseway Capital Management0.22%$19.8M54.03KNew+54.03KQ3 2026
5TemasekTemasek Holdings0.21%$75.2M205.47K▼ Reduced 76%−640.42KQ3 2026
6John Overdeck and David Siegel (founders)Two Sigma Investments0.18%$240.3M656.71K▲ Added 129%+370.16KQ3 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of ONC by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 20269245.82M$2.1B22
Q2 2026157416.08M$4.6B32
Q1 2026157616.7M$5B12
Q4 2025157515.73M$4.8B02
Q3 2025157515.93M$5.4B13
Q2 2025157616.16M$3.9B24
Q1 2025156820.85M$5.7B15
Q4 2024156723.99M$4.4B14

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of ONC held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Primecap team4.91M5.01M4.98M4.98M5.08M5.09M5.06M5.1M
John Overdeck and David Siegel (founders)656.71K———————
Temasek205.47K845.73K862.64K919.59K1.01M1.01M993.75K1.53M
Sarah Ketterer54.03K———————
Julian and Felix Baker·8.8M8.8M8.8M8.8M8.8M8.8M9.53M
Ken Griffin·1.43M1.03M———982.16K—
Zhang Lei·—1.03M1.03M1.03M1.03M1.03M3.8M
Andrew Spokes——1.1K1.1K1.1K1.1K1.1K1.1K
Saudi Public Investment Fund—————227.18K354.39K354.39K
Baillie Gifford team——————3.63M3.67M

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own ONC?

In their latest 13F filings: Julian and Felix Baker (12.6% of the portfolio, $2.5B), Primecap team (1.11% of the portfolio, $1.8B), Ken Griffin (0.23% of the portfolio, $406.2M), Sarah Ketterer (0.22% of the portfolio, $19.8M), Temasek (0.21% of the portfolio, $75.2M), John Overdeck and David Siegel (founders) (0.18% of the portfolio, $240.3M).

Who bought ONC last quarter?

Julian and Felix Baker (added 0.0%), Ken Griffin (added 38%), Sarah Ketterer (new position), John Overdeck and David Siegel (founders) (added 129%). “Last quarter” is each investor's latest reported quarter.

Who sold ONC last quarter?

Reduced: Primecap team (2.0% fewer shares), Temasek (76% fewer shares). Sold out entirely: Zhang Lei (was $307.2M).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns BeOne Medicines (ONC)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/ONC/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to ONC by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.